Small-fiber polyneuropathy (SFPN) causes non-specific symptoms including chronic
pain, cardiovascular, gastrointestinal, and sweating complaints. Diagnosis is made from
history and exam in patients with known risk factors such as diabetes, but objective test
confirmation is recommended for patients without known risks. If tests confirm SFPN, and
it is “initially idiopathic” (iiSFPN), screening for occult causes is
standard. This study’s aim was to evaluate the 21 widely available, recommended
blood tests to identify the most cost-effective ones and to learn about occult causes of
iiSFPN. Records were reviewed from all 213 patients with SFPN confirmed by distal-leg skin
biopsy, nerve biopsy, or autonomic-function testing in our regional center during 2013. We
determined the prevalence of each abnormal blood-test result (ABTR) in the iiSFPN cohort,
compared this to population averages, and measured the costs of screening subjects to
obtain one ABTR. Participants were 70% female and 43.0±18.6 years old.
High erythrocyte sedimentation rate (ESR) and antinuclear antibody (ANA; ≥1:160
titer) were each present in 28% of subjects. The ABTR ≥ 3× more
prevalent in iiSFPN than in the total population were high ESR, high ANA, low C3,
Sjögren’s and celiac autoantibodies. Together, these suggest the
possibility of a specific association between iiSFPN and dysimmunity. ATR identifying
diabetes, prediabetes, and hypertriglyceridemia were less common in iiSFPN than in the
population and thus not associated with iiSFPN here. Reimbursement for the 6 most
cost-effective iiSFPN-associated blood tests–ESR, ANA, C3, autoantibodies for
Sjögren’s and celiac, plus thyroid-stimulating hormone–was
$99.57/person with 45.6% sensitivity for detecting one abnormal result.
Angiotensin-converting enzyme was elevated in 45% but no patients had sarcoidosis,
so this test was futile here.